Some Thoughts On JNJ and Abbott Labs

Some Thoughts On JNJ and Abbott Labs

Some Thoughts On JNJ and Abbott Labs
  • It seems that 2007 should be a brighter year for Johnson & Johnson (NYSE JNJ).  In 2006 the company faced major drug expirations which dampened revenue growth.
  • I really like the Pfizer’s (PFE) consumer business acquisition. Despite having a fairly good product line, Pfizer Inc was a pharmaceutical company that happened to have consumer products which came with the Warner Lambert acquisition. JNJ on the other hand has a culture of running diverse healthcare and consumer businesses.
  • It reminds me of 3M Company (NYSE MMM), as there is a synergy between different operating units as they share their R&D findings.
  • JNJ has a greater global consumer distribution network than Pfizer, therefore, it will be able to increase sales of PFE’s consumer unit by taking the products to places that they’ve not gone before (sounds Star Treckish, doesn’t it?)
  • Abbott Laboratories (ABT) received an incredible price (34 times operating earnings) for its diagnostic unit that was sold to General Electric (NYSE GE) (great job!).
  • I always looked at ABT as a mini-JNJ; it is a diversified healthcare company which is not heavily dependent on blockbusters. The company had a good quarter and should have a good next year. It is trading at about 18x earnings, higher valuation than JNJ’s 15x earnings, but it should have a bit higher growth rate.

Please read the following important disclosure here.

Enjoyed this read?

Share it with someone who’d love it too!

Related Articles

The Paranoid Russian Jew Approach to Investing

The Paranoid Russian Jew Approach to Investing

When asked about his money manager, our long-term client Ed, who became a dear friend, proudly stated, “My money is managed by a paranoid Russian Jew.” This perfectly sums up our approach to investing.
A Value Investing Lesson from the Blackjack Table

A Value Investing Lesson from the Blackjack Table

Over a lifetime, active value investors will make hundreds, often thousands of investment decisions. Not all of those decisions will work out for the better.
Q&A Series: Diversification and Position Sizing in Investing

Q&A Series: Diversification and Position Sizing in Investing

Today's excerpts from Q&A session I held in Omaha focuses on crucial investment strategies: diversification and position sizing in investing.
The Hidden Advantages of Investing from NOT New York City

The Hidden Advantages of Investing from NOT New York City

What are the hidden advantages of living away from “noisy” investing centers like New York? 

Leave a Comment